Prevalence of anti-R-13 antibodies in human<i>Trypanosoma cruzi</i>infection

Christine Aznar, Pablo Lopez‐Bergami, Silvia Brandariz, Christine Mariette, Pascale Liégeard, Maria do Carmo de Deus Alves, Erika Luna Barreiro, Roxana Carrasco, Sonia Lafon, Dan Kaplan,

FEMS Immunology & Medical Microbiology · 1995 · 35 citations · 14 references

Concepts

Abstract

Infection with Trypanosoma cruzi develops in three phases: acute, indeterminate or asymptomatic, and chronic phase (with cardiac or digestive manifestations). Moreover, transmission may occur from infected mothers to newborn, the so-called congenital form. In the present study, humoral responses against T. cruzi total extract and against the 13 amino acid peptide named R-13 derived from the parasite ribosomal P protein, previously described as a possible marker of chronic Chagas heart disease, were determined in chagasic patients and in blood bank donors from endemic areas. While in sera from acute phase, only IgM anti-T.cruzi response was observed, both IgM and IgG anti-T. cruzi antibodies were detected in sera from congenitally infected newborns. The percentage of positive response in sera from blood bank donors was relatively high in endemic regions. Antibodies against the R-13 peptide were present in a large proportion of cardiac chagasic patients but were totally lacking in patients with digestive form of Chagas' disease. Furthermore, anti-R-13 positive responses were detected in congenitally infected newborns.

References

14